The Dark Side of the Matrix: Elastin-Derived Fragments Drive Aging by Igniting the Immune System.
Abstract
The extracellular matrix (ECM) undergoes extensive alterations during aging, yet its contribution to organismal aging remains partially understood. Emerging evidence now identifies elastin-derived fragments as bioactive matrikines that function as systemic drivers of inflammaging and aging, rather than passive byproducts of tissue degradation. This Viewpoint examines recent findings on elastin-derived fragments in the context of matrikine biology and aging, highlighting their emerging roles as mediators of inflammaging and systemic aging. It further discusses the implications of these discoveries for understanding the mechanisms of aging and explores their potential to inspire novel therapeutic strategies for age-related diseases.
The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.
Research summary
The paper proposes that elastin-derived fragments act as systemic drivers of inflammaging, suggesting that targeting these matrikines could mitigate age-related physiological decline. This viewpoint is relevant because it addresses inflammaging, a core hallmark of aging, by identifying a specific mechanistic driver (ECM degradation products) rather than merely correlating with disease symptoms, although as a viewpoint paper it likely lacks the primary experimental data to claim high impact.
Author of this paper? Send a correction.